Viokace Tablet
Product Images NDC 73562-104

This is a medication called Viokace (pancrelipase) which contains 10,440 USP Units Lipase, 39,150 USP Units Amylase and 39,150 USP Units Protease. It is distributed by Nestlé HealthCare Nutrition, Inc and manufactured in Canada. The tablets should not be crushed or chewed and are dosed based on lipase units. The medication guide should be given to each patient. The dosage information can be found in the package insert. It is important to not use the tablets if the foil seal under the cap is broken or missing. The medication should be stored at 20-25°C (68-77F) in a dry place, away from moisture and excessive heat, and kept out of reach of children. All trademarks are owned by Société des Produits Nesflé S. Vevey, Switzerland.*

This is a description of a medication called Viokace manufactured in Canada and distributed by Nestlé HealthCare Nutrition Inc. Each tablet contains 20,880 USP units, 78,300 USP Units Amylase, and 78,300 USP Units Protease, and should be swallowed whole, without crushing or chewing. Dosage information is to be found in the package insert. It is important to not use Viokace if the seal under the cap is broken or missing. The medication should be stored in a dry place, at a temperature between 20-25°C (68-77°F), and in a right container, protected from moisture and excessive heat, and kept away from children. More information can be found at the website of the manufacturer.*